Correlation Between Stoke Therapeutics and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Stoke Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Pliant Therapeutics.
Diversification Opportunities for Stoke Therapeutics and Pliant Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Pliant is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Pliant Therapeutics
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.34 times more return on investment than Pliant Therapeutics. However, Stoke Therapeutics is 1.34 times more volatile than Pliant Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 1,127 in Stoke Therapeutics on November 2, 2024 and sell it today you would lose (28.00) from holding Stoke Therapeutics or give up 2.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Pliant Therapeutics
Performance |
| Timeline |
| Stoke Therapeutics |
| Pliant Therapeutics |
Stoke Therapeutics and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Pliant Therapeutics
The main advantage of trading using opposite Stoke Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Stoke Therapeutics vs. Surrozen | Stoke Therapeutics vs. Armata Pharmaceuticals | Stoke Therapeutics vs. Pasithea Therapeutics Corp | Stoke Therapeutics vs. Aditxt Inc |
| Pliant Therapeutics vs. Surrozen | Pliant Therapeutics vs. Armata Pharmaceuticals | Pliant Therapeutics vs. Pasithea Therapeutics Corp | Pliant Therapeutics vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |